Autres langues Pacific Biosciences of California, Inc.

Actions

PACB

US69404D1081

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/05/2024			Varia. 5j.	Varia. 1 janv.
2,145 ^USD	-3,81 %		+27,68 %	-78,13 %

15/05	Pacific Biosciences et Ambry Genetics sélectionnés pour séquencer jusqu'à 7 000 génomes humains	MT
15/05	PACIFIC BIOSCIENCES OF CALIFORNIA, INC. : Morgan Stanley confirme sa recommandation neutre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes	15/05
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases	15/05
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation	10/05
Pacific Biosciences: Q1 Earnings Snapshot	09/05
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M	09/05
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
PacBio Announces First Quarter 2024 Financial Results	09/05
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries	01/05
Sector Update: Health Care Stocks Higher Late Afternoon	16/04
Sector Update: Health Care	16/04
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	16/04
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance	16/04
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	16/04
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
PacBio Grants Equity Incentive Award to New Employee	22/03
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions	12/03
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	12/03
PacBio to Present at Upcoming Investor Conferences	26/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Pacific Biosciences of California, Inc.

Actions

PACB

US69404D1081

Autres langues

Filtres